Soleno Therapeutics (SLNO) News Today $54.40 +0.85 (+1.59%) (As of 12:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Soleno Therapeutics (NASDAQ:SLNO) Reaches New 52-Week High at $54.32Soleno Therapeutics (NASDAQ:SLNO) Reaches New 12-Month High at $54.32September 17 at 5:53 PM | marketbeat.comSofinnova Investments Inc. Raises Stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Sofinnova Investments Inc. increased its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 267.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 554,359 shares of the company's stock afteSeptember 17 at 7:38 AM | marketbeat.comSoleno Therapeutics to Present at 2024 Cantor Global Healthcare ConferenceSeptember 16 at 4:05 PM | globenewswire.comBrokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) Target Price at $67.14September 15, 2024 | americanbankingnews.comBank of New York Mellon Corp Acquires Shares of 88,799 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Bank of New York Mellon Corp bought a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 88,799 shares of the company's stock, valued at approximately $3,623,000. Bank of New YorSeptember 15, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading VolumeSoleno Therapeutics (NASDAQ:SLNO) Sees Strong Trading VolumeSeptember 13, 2024 | marketbeat.comTD Asset Management Inc Boosts Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)TD Asset Management Inc boosted its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 174.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,534 shares of the company's stock aSeptember 13, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by BrokeragesShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been given an average recommendation of "Buy" by the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation and one has givenSeptember 12, 2024 | marketbeat.comSoleno Therapeutics (SLNO) Receives a Buy from Piper SandlerSeptember 11, 2024 | markets.businessinsider.comSoleno Therapeutics, Inc. to Post Q3 2024 Earnings of ($0.56) Per Share, HC Wainwright Forecasts (NASDAQ:SLNO)Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Investment analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Soleno Therapeutics in a note issued to investors on Tuesday, September 3rd. HC Wainwright analyst R. Selvaraju expects that the compaSeptember 6, 2024 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Soleno Therapeutics (SLNO) with Buy RecommendationSeptember 5, 2024 | msn.comBuy Rating on Soleno Therapeutics: Advancing PWS Treatment with DCCR and Anticipating FDA ApprovalSeptember 3, 2024 | markets.businessinsider.comSoleno Therapeutics (NASDAQ:SLNO) Receives New Coverage from Analysts at HC WainwrightHC Wainwright initiated coverage on Soleno Therapeutics in a research report on Tuesday. They set a "buy" rating and a $70.00 price objective for the company.September 3, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Bought by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 28.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 133,58September 1, 2024 | marketbeat.comKristen Yen Sells 5,270 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) StockAugust 31, 2024 | insidertrades.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) CFO James H. Mackaness Sells 6,661 SharesAugust 31, 2024 | insidertrades.comBuy Rating for Soleno Therapeutics Amidst Favorable Regulatory Developments for DCCRAugust 30, 2024 | markets.businessinsider.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Up 4.1%Soleno Therapeutics (NASDAQ:SLNO) Trading Up 4.1%August 30, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Sells $4,722,000.00 in StockAugust 30, 2024 | insidertrades.comFDA sets decision date on Peninsula biotech’s eating disorder drugAugust 28, 2024 | bizjournals.comSoleno Therapeutics, Inc. (SLNO): One of Oppenheimer’s Top Stock Picks For the Next 12 MonthsAugust 28, 2024 | finance.yahoo.comSoleno Therapeutics Target of Unusually Large Options Trading (NASDAQ:SLNO)Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) saw unusually large options trading on Tuesday. Traders purchased 8,829 put options on the stock. This is an increase of 1,271% compared to the average volume of 644 put options.August 28, 2024 | marketbeat.comSoleno Shares Climb After FDA Grants Priority Review for Diazoxide Choline ApplicationAugust 27, 2024 | marketwatch.comSoleno Therapeutics: 2 New Catalysts To Bring Forth Change For PWS PatientsAugust 27, 2024 | seekingalpha.comSoleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi SyndromeAugust 27, 2024 | globenewswire.comSoleno Therapeutics (NASDAQ:SLNO) Shares Down 6.8% Soleno Therapeutics (NASDAQ:SLNO) Stock Price Down 6.8%August 22, 2024 | marketbeat.comSG Americas Securities LLC Buys Shares of 13,941 Soleno Therapeutics, Inc. (NASDAQ:SLNO)SG Americas Securities LLC purchased a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 13,941 shares of the company's stock, valued at approximateAugust 20, 2024 | marketbeat.comSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 19, 2024 | globenewswire.comSLNO Jan 2025 45.000 putAugust 19, 2024 | ca.finance.yahoo.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Rating of "Buy" by BrokeragesSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) has earned a consensus rating of "Buy" from the seven analysts that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buyAugust 18, 2024 | marketbeat.comAssenagon Asset Management S.A. Buys Shares of 729,841 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Assenagon Asset Management S.A. bought a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 729,841 shares of the company's stock, vaAugust 17, 2024 | marketbeat.comSLNO Mar 2025 65.000 callAugust 17, 2024 | ca.finance.yahoo.comSoleno Therapeutics Announces Updates to its Board of DirectorsAugust 15, 2024 | finance.yahoo.comOppenheimer Raises Soleno Therapeutics (NASDAQ:SLNO) Price Target to $65.00Oppenheimer increased their target price on shares of Soleno Therapeutics from $59.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday.August 12, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Announces Earnings Results, Beats Expectations By $0.06 EPSSoleno Therapeutics (NASDAQ:SLNO - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.57) EPS for the quarter, topping analysts' consensus estimates of ($0.63) by $0.06.August 11, 2024 | marketbeat.comBuy Rating for Soleno Therapeutics: Anticipated FDA Nod and Strong Financials Underpinning SuccessAugust 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: MannKind (MNKD), Envista Holdings (NVST) and Soleno Therapeutics (SLNO)August 8, 2024 | markets.businessinsider.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells $229,628.09 in StockAugust 8, 2024 | insidertrades.comBhatnagar Anish Sells 58,213 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) StockAugust 8, 2024 | insidertrades.comSLNO Stock Earnings: Soleno Therapeutics Beats EPS for Q2 2024August 8, 2024 | investorplace.comPrice T Rowe Associates Inc. MD Buys Shares of 152,620 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Price T Rowe Associates Inc. MD acquired a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 152,620 shares of the companAugust 5, 2024 | marketbeat.comNoteworthy Tuesday Option Activity: SLNO, EA, TRUAugust 1, 2024 | nasdaq.comSoleno Therapeutics' (SLNO) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $67.00 target price on shares of Soleno Therapeutics in a report on Wednesday.July 31, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Stock Holdings Increased by Janus Henderson Group PLCJanus Henderson Group PLC raised its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 13.7% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,870,811 shares of the company's stock after buying an additiJuly 31, 2024 | marketbeat.comWhen Can We Expect A Profit From Soleno Therapeutics, Inc. (NASDAQ:SLNO)?July 29, 2024 | finance.yahoo.comPeninsula biotech lines up employees for stock bonuses triggered by FDA decisionsJuly 24, 2024 | bizjournals.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 4.1%Soleno Therapeutics (NASDAQ:SLNO) Stock Price Up 4.1%July 23, 2024 | marketbeat.comSoleno Therapeutics, Inc. (SLNO)July 19, 2024 | nz.finance.yahoo.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 6.9%Soleno Therapeutics (NASDAQ:SLNO) Stock Price Up 6.9%July 12, 2024 | marketbeat.comInsider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 2,170 Shares of StockJuly 4, 2024 | insidertrades.com Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. SLNO Media Mentions By Week SLNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼1.050.56▲Average Medical News Sentiment SLNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼73▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Rhythm Pharmaceuticals News Edap Tms News Rockwell Medical News FONAR News Glaukos News Inspire Medical Systems News Bausch + Lomb News TransMedics Group News PROCEPT BioRobotics News Axonics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredTrump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absoluteDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredKamala Harris To Tank the Market?URGENT ELECTION MELTDOWN WARNING From the former CIA advisor who predicted President Trump’s win in 2016…Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soleno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free slno Stock Alerts